CapitalBio® NIPT
6Pages

CapitalBio® NIPT Non-Invasive Prenatal Testing (NIPT) for Fetal Chromosomal Building C, 88 Kechuang 6th Street, Yizhuang Biomedical Park Beijing Economic-Technological Development Area Beijing 101111 China Tel: +86-10-69002900 Fax: +86-10-69002988 Email: globalsales@capitalbiotech.com Website : http://www.capitalbiotech.com CapitalBio Technology CapitalBio Genomics

CapitalBio®tNIPT TPIN ®oiBla ipaC CapitalBio® NIPT The incidence of chromosomal abnormalities is as high as 1 in 60 in China 1. The incidence increases with maternal age and can reach 2.5% with maternal age over 351. Among those with chromosomal abnormalities, fetuses with Trisomy 21 (Down Syndrome), Trisomy 18 (Edward Syndrome), and Trisomy 13 (Patau Syndrome) are most likely to survive. Therefore detection of the chromosomal abnormalities are most clinically significant. Who Should be Offered CapitalBio NIPT ？ 1.Pregnant women with indicators suggesting high risk of fetal aneuploidies who...

CPIN ®oiBlatNIPT T apitalBio® ipaC CapitalBio® NIPT CapitalBio® NIPT Test CapitalBio NIPT test can detected Trisomy 21,18,13, sex chromosome aneuploidies (45,X), (47,XXY), (47,XYY) and 300 Microdeletions/ Microduplications from maternal blood since the ninth week of pregnancy (9+0 weeks since LMP). If desired, the gender of the fetus may also be determined. Safe Rapid Affordable The CapitalBio NIPT based on semiconductor sequencing technology offers a wide range of applications and also ensures a more cost-effective and rapid analysis. Measures are taken in each step to ensure high quality...

CPIN ®oiBlatNIPT T apitalBio® ipaC CapitalBio® NIPT Prenatal Screening Strategy Detection/Screening of fetal trisomy 21, 18, 13 Sex chromosome aneuploidies (45,X), (47,XXY), (47,XYY), if detected Gestation week: 9 Detection/Screening of fetal trisomy 21, 18, 13 and other 300 common chromosomal microdeletions/microduplicaitons.*(over 1Mb5) Sex chromosome aneuploidies (45,X), (47,XXY), (47,XYY), if detected Gestation week: 12 References All positive results must be verified by chromosome karyotyping 1.Zhang YP., et al.,(2011) Karyotype analysis of amniotic fluid cells and comparison of...

CPIN ®oiBlatNIPT T apitalBio® ipaC CapitalBio® NIPT Product information Introduction of BES 4000 System CapitalBio BioelectronSeq 4000 System is a next- Specications for BioelectronSeq 4000 Server Product configuration A single free-standing tower computer, included with the purchase of the BioelectronSeq 4000 System. Includes Torrent SuiteTM Software with all necessary software components to deliver signal processing, base calling, read alignment, and variant calling. produced by CapitalBio Corporation in collaboration with Thermo Fisher Scientific Inc. in China. The s y st e m a d o pt s...

CPIN ®oiBlatNIPT T apitalBio® ipaC CapitalBio® NIPT Introduction of BES 4000 Software CapitalBio® Data Analysis & Management Software for Noninvasive Prenatal Testing is a multifunctional software system that integrates the functions of One-click Report Printing Non-invasive Prenatal Testing for Fetal Chromosomes 21, 18 and 13 Patient and Provider Information Patient ID: Clinic Name: The Clinic Offering Test Patient Name: Zhang San data analysis and management, including sample Referring/Ordering Clinician: Sample Collected: DD/MM/YY Gestational Age:17w+6 Medical Record: information entry,...